Tambotatug Pelitecan Delivers a Major Survival Gain in Relapsed SCLC: TAISHAN-302 Establishes B7-H3 as a Therapeutic Target
FDA Approves Floretyrosine F 18 for PET Imaging in Glioma
Cancer Immunotherapy: 2016 vs 2026
ACT 4 Children Calls for Global Action and Healthcare Equity During Childhood Cancer Awareness Month
Diego A. Díaz-García: PAPILLON Delivers New Overall Survival Data in EGFR Ex20ins NSCLC
10 Must-Read Posts In GU Oncology This Week
Trastuzumab Deruxtecan Improves PFS in First-Line HER2-Mutant NSCLC in DESTINY-Lung04
Jose Pacheco: Tambotatug Pelitecan Shows Superior Survival in Small Cell Lung Cancer
The ESOI Touchdown 2026 will take place from October 29–31, 2026, at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. The in-person congress will bring together radiologists, clinicians, scientists, patients, and industry partners to explore current developments and future directions in oncologic imaging. The scientific program will cover artificial intelligence in oncologic diagnostics, innovative […]
